With the rise of respiratory illnesses like COVID-19, Flu A, and Flu B, efficient and accurate testing is vital. As of July 2024, SARS-CoV-2 has caused over 760 million cases worldwide, and seasonal flu affects millions each year. Quick, precise diagnosis is key to effective management. Traditional methods can be cumbersome for rapid, frequent testing.
This kit provides a streamlined solution for in vitro detection of SARS-CoV-2, Influenza A, and Influenza B RNA in nasal swab samples.

Respiratory viruses like Flu A, Flu B, and RSV significantly impact global health, with influenza causing up to 650,000 deaths annually and RSV leading to 2.1 million outpatient visits among U.S. children under 5. Frequent testing can be burdensome and complex. This kit provides a streamlined solution for in vitro qualitative detection of Influenza A, Influenza B, and RSV in nasal, nasopharyngeal, or oropharyngeal swabs.

Accurate testing for strep throat is essential due to the high incidence of Group A Streptococcus (GAS) infections, affecting millions annually. In the U.S., there are about 11 million cases of pharyngitis, many caused by GAS. Effective testing reduces complications and unnecessary antibiotics, with rapid tests improving management and reducing costs. Our Strep A Nucleic Acid Test Card offers a quick, accurate, and easy way to detect Strep A from oropharyngeal swabs.